Pharma Marketing Network

Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition, describes a urine analysis mobile app that illustrates why the mobile health app industry needs more consistent and balanced FDA enforcement of mobile regulations.

In this 3.5-minute audio snippet, Bill Evans, Executive Vice President and Chief Digital Officer for Team Chemistry @ WPP, and Zoe Dunn, Principal at Hale Advisors, Inc., talk about their disappointment with speakers at industry digital and social media conferences whose presentations lack depth and most important do not showcase their success stories so that attendees can actually learn something. It's not about revealing the

The drug industry is reeling from criticism about drug prices coming from all sides and especially from the president of the United States. First it tried public relations and CEO speaking tours. When that didn’t work it took more drastic action.

In this 2.5-minute audio snippet, Jack Barrette and Fabio Gratton, talk about Truvio and the importance of the patient voice in market research and how to distill the sentiment from patient conversations.

In this 2.5-minute audio snippet, Patricia Alves and Jaclyn Fonteyne, members of the Boehringer Ingelheim Social Media Team, talk about the working with legal-regulatory to plan TweetChats and what they consider to be the measures of success -- aka, return on investment -- for pharma TweetChats.

In this 3-minute audio snippet, Arsalan Arif, Publisher of ENDPOINTS, talks about the benefits versus the drawbacks of content curation versus content marketing for pharmaceutical marketers.

In this 2-minute audio snippet, Anne C. Beal, M.D., MPH, Sanofi, talks about patient centricity and Sanofi's commitment to engaging patients and improving outcomes.

In this 3-minute audio snippet, Andrew Schorr, Founder and Host of PatientPower.info, notes that pharma agency accounts come and go, but patients are living with their conditions day in and day out. Pharma has to be careful, says Schorr, when approaching patients about how they view the commitment.

In this 2-minute audio snippet, Ambre Morley, Associate Director, Product Communications, Novo Nordisk, talks about vetting Paula Deen as a paid celebrity spokesperson for the Novo Victoza diabetes drug franchise and the importance of measuring celebrity return on investment (ROI).

You have to give kudos to the good doctors and policy makers of the American Medical Association for trying over the course of many to ban or in some way curtail direct-to-consumer drug ads by pharmaceutical companies. The latest effort focuses on drug price transparency in ads. Will it succeed where the other efforts have failed?